...
首页> 外文期刊>Protein engineering design & selection: PEDS >Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability.
【24h】

Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability.

机译:具有增强的稳定性的全活性PXR / SRC-1拴系蛋白的构建和表征。

获取原文
获取原文并翻译 | 示例

摘要

The nuclear xenobiotic receptor PXR is a ligand-inducible transcription factor regulating drug-metabolizing enzymes and transporters and a master switch mediating potentially adverse drug-drug interactions. In addition to binding a coactivator protein such as SRC-1, the C-terminal ligand-binding domain (LBD) is solely responsible for ligand recognition and thus the ligand-dependent downstream effects. In an effort to facilitate structural studies of PXR to understand and abolish the interactions between PXR and its ligands, several recombinant PXR/SRC-1 constructs were designed and evaluated for expression, stability and activity. Expression strategies employing either dual expression or translationally coupled bicistronic expression were found to be unsuitable for producing stable PXR in a stochiometric complex with a peptide derived from SRC-1 (SRC-1p). A single polypeptide chain encompassing PXR and SRC-1p tethered with a peptidyl linker was designed to promote intramolecular complex formation. Thistethered protein was overexpressed as a soluble protein and required no additional SRC-1p for further stabilization. X-ray crystal structures in the presence and absence of the known PXR agonist SR-12813 were determined to high resolution. In addition, a circular dichroism-based binding assay was developed to allow rapid evaluation of PXR ligand affinity, making this tethered protein a convenient and effective reagent for the rational attenuation of drug-induced PXR-mediated metabolism.
机译:核外源生物受体PXR是调节药物代谢酶和转运蛋白的配体诱导转录因子,是介导潜在不良药物相互作用的主开关。除了结合诸如SRC-1之类的共激活蛋白外,C末端配体结合域(LBD)仅负责配体识别,因此也依赖配体依赖性下游作用。为了促进PXR的结构研究以理解和消除PXR及其配体之间的相互作用,设计了几种重组PXR / SRC-1构建体并评估了其表达,稳定性和活性。发现采用双重表达或翻译偶联双顺反子表达的表达策略不适合在化学计量配合物中与衍生自SRC-1(SRC-1p)的肽中产生稳定的PXR。包含PXR和SRC-1p的单个多肽链与肽基接头连接在一起,旨在促进分子内复合物的形成。该拴系蛋白过表达为可溶性蛋白,不需要其他SRC-1p即可进一步稳定。确定存在和不存在已知PXR激动剂SR-12813的X射线晶体结构具有高分辨率。此外,还开发了一种基于圆二色性的结合测定法,可以快速评估PXR配体的亲和力,从而使这种束缚蛋白成为合理减弱药物诱导的PXR介导的代谢的方便有效的试剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号